And she told them about a night six days before Arthur died, when Mark had returned home after midnight furious and shaken. He had said Arthur was threatening to ruin the company over a misunderstanding. Sarah remembered Mark opening a bottle of whiskey in the kitchen and saying, “Your father is going to regret humiliating me.” At the time, she had dismissed it as anger.
Now she did not.
The financial case moved first.
Bank records showed that the $600,000 had not been invested in Meridian Strategic Holdings in any conventional sense. The transfers had covered payroll shortfalls, personal debt, a luxury vehicle lease, and a private bridge loan Mark had failed to disclose to Sarah. More troubling, investigators found attempted transfers totaling another $240,000 that had been rejected after Arthur changed his online credentials.
The device records matched what I had already found.
So did the signatures.
Mark’s attorney began calling the transfers “informal family financing.”
Then the independent document examiner retained by the state concluded that Arthur’s signatures on two authorization forms were simulated from older specimens.
The phrase sounded almost gentle.
The act was not.
Three weeks after Sunday dinner, Mark was charged with financial exploitation, forgery, computer-related fraud, and attempted theft. Bail conditions prohibited him from contacting me about the investigation or accessing any account connected to Arthur’s estate.
Sarah filed for separation the same afternoon.
But the question of Arthur’s death remained.
That was the question that woke me at three in the morning.
The preserved blood sample had been drawn after Arthur complained of unusual dizziness and nausea. His physician had ordered routine tests. The original panel had not included a broad toxicology screen. After his sudden death the following day, no one thought to connect the sample to what had happened. Arthur had heart disease. His death had been certified as a cardiac event.
My attorney had only requested further review after finding the note about Mark and seeing the timing.
The first laboratory had identified a sedating prescription compound that had never been ordered for Arthur.
The state laboratory confirmed it.
Then came a second finding: the concentration was high enough that, in combination with Arthur’s cardiac medication, it could have caused severe hypotension, disorientation, and a dangerous rhythm disturbance.
Could have.
Not did.
I learned to hate those two words.
Raines explained the distinction carefully. “Toxicology tells us what was in his body. It does not tell us who put it there.”
I appreciated that too, even though part of me wanted certainty more than fairness.
Investigators reconstructed Arthur’s final forty-eight hours. Pharmacy records showed no prescription. His doctors had not administered the drug. I had not taken it. Sarah had never used it.
Mark had.
A pharmacy loyalty record and insurance rejection showed that he had purchased the same medication for a back injury eight months earlier. That still did not prove he gave any to Arthur.
Then Sarah remembered something else.
“The coffee,” she said.
We were in Detective Ortiz’s office when the memory surfaced.
